Kivu Bioscience

Valink Therapeutics

Valink Therapeutics develops next-generation bispecific antibody-drug conjugates to treat solid tumours for cancer patients.

Callio Therapeutics

The company develops multi-payload antibody-drug conjugates to treat cancer patients.

Stipple Bio

Stipple Bio develops a platform for mapping tumour-specific epitopes to create precision oncology medicines and antibody-drug conjugates for cancer patients.

Avidicure

This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.

Promatix

Promatix develops antibody-drug conjugates for cancer treatment using a proprietary multi-omics platform to identify and target specific tumour markers.

Mablink Bioscience

This biotechnology firm develops antibody-drug conjugates for pharmaceutical companies to treat cancer using a proprietary hydrophilic linker platform.

Angiex

This company develops antibody-drug conjugates for clinicians and pharmaceutical partners to treat solid cancers and vascular diseases.